1 perimental annotations of intrinsic disorder
are available for 0.1% of 147 000 000 of currently seque
2 Outcome data
was available for 1,165 women, 6.7% of whom had sPTB, 16
3 Follow-up measures of linkage
were available for 1,128 (77%) and BP for 1,106 (76%).
4 Complete data
were available for 1,165 participants.
5 nd Main Results: Genome-wide genotyping data
were available for 1,699 individuals with ILAs and 10,27
6 ed the voucher, and follow-up data at 1 year
were available for 10 802 patients (98.2%).
7 Methods: Data
were available for 10 patients with neuroendocrine tumor
8 Data
were available for 100 subjects with severe asthma (medi
9 tile range, 19 to 21), and data on mortality
were available for 100% of participants.
10 Data
were available for 1001 individuals of white European an
11 Follow-up data
were available for 1014 patients who were included in th
12 Complete VA deterioration information
was available for 1020 patients, and complete informatio
13 Outcome data at 1 year after spinal injury
were available for 1031 patients (66.6%).
14 Ct data
were available for 106 (71%) of 150 enrolled index patie
15 Primary outcome data
were available for 1072 patients in the intensive group
16 ng with repeat testing after return to shore
was available for 120 of the 122 persons on board over a
17 Follow-up data
were available for 125 eyes of 70 patients.
18 Pathologic confirmation
was available for 143 nodules (122 HCCs, 18 non-HCC mali
19 Primary outcome data
were available for 1692 infants (92.8%).
20 At 12 months, OSS data
were available for 189 (94%) of 201 participants assigne
21 ents and on death from cardiovascular causes
were available for 203 (95%) and 214 (100%), respectivel
22 Data on the primary outcome
were available for 206 women (81%).
23 Data
were available for 214 patients for the primary analysis
24 mal baseline EF, information on follow-up EF
was available for 216, of whom 90 (42%) recovered their
25 Outcome data
were available for 2391 (97.7%) participants, and 6% (14
26 measures (with a mean follow-up of 6 years)
were available for 242 mutation carriers and 262 non-car
27 Structural magnetic resonance imaging data
were available for 250 participants.
28 entified reviews and malpractice claims data
were available for 264 surgeons from 2000 to 2015.
29 PET/CT scans and pathology findings
were available for 270 N0 neck sides from 212 participan
30 Of 1046 eligible eyes, 10-year data
were available for 293 (28%), which were included in the
31 Data
were available for 305 pwMND (mean age at diagnosis=62.2
32 Primary outcome data
were available for 306 (85%) of 362 participants allocat
33 Breast milk samples
were available for 31 LOD cases (8 serotype Ia and 23 se
34 Visual acuity measurements
were available for 3240 (95.3%) participants.
35 bitual coffee intake and relevant covariates
were available for 347,077 individuals in the UK Biobank
36 T, and aHCV measurements at 0.6 to 4.1 years
were available for 35% to 63% of the sample.
37 PD-L1 status
was available for 36 patients; 15 (42%) had >= 1% expres
38 Complete outcome and covariate data
were available for 4,428 and 4,369 participants at ages
39 mic regions involved in isoniazid resistance
were available for 4,563 patients.
40 4-month follow-up data
were available for 406 (64%) participants, 25 were lost
41 Biannual series
were available for 422 eyes of 214 participants.
42 Data
were available for 455 state-years from 48 states, inclu
43 018, complete data for the primary endpoints
were available for 474 (97%) individuals.
44 Data
was available for 516, 424 and 455 patients at baseline,
45 Genetic and structural MRI data
were available for 516 healthy non-Hispanic Caucasian un
46 Ventilation rates
were available for 52 events (47 patients).
47 Abdominal CT or MRI
was available for 53 of 90 patients.
48 Baseline data
were available for 593 women in the intervention (93.3%
49 Toxicokinetic or pharmacokinetic analysis
was available for 61 patients (13 chloroquine, three hyd
50 Five-year photographs
were available for 615/862 (71%) eligible patients.
51 Research and development expenditures
were available for 63 (18%) products, developed by 47 di
52 Data
were available for 75,839 individuals prescribed PrEP, a
53 Of the 804 PACG patients, genotyping data
were available for 768 individuals and included 436 with
54 n Results: NO(2) exposures at birth or age 6
were available for 777 children with one or more CC16 me
55 4.6+/-2.9%), clinical follow-up information
was available for 778 (98%) patients.
56 15-20 year follow-up data
was available for 79 (41 Nissen, 38 anterior).
57 In contrast, data
were available for 79% of eligible articles, highlightin
58 ents were included, of whom seizure outcomes
were available for 8191 (89.5%) participants at 2 years,
59 Primary outcome data
was available for 88% (rosuvastatin n = 20, control n =
60 Vaccination data
were available for 91 (83%) cases; 51 (56%) had 2 RV1 do
61 otic administration, and signs of infection)
were available for 98.7% randomized to the probiotic gro
62 Fracture data
were available for 9802 of the 9803 participants.
63 Complete follow-up data
were available for 99.2% of the neonates.
64 27) in the control group; data on mortality
were available for 99.9% of patients in the study.
65 d complete information on late complications
was available for 991 patients.
66 we show that, if time-resolved measurements
are available for a number of overlapping peptides that
67 This technique has
been available for a decade, yet the current state and s
68 CO(2) flux have been biased by observations
being available for a relatively small number of accessi
69 Survival data
was available for a subset of patients.
70 tes for each lag when at least three studies
were available for a specific lag.
71 Additional pathological comparisons that
were available for a subset in ADNI suggested that subty
72 , and digested grains, only a small fraction
was available for absorption in the gut, with amounts va
73 Few or no effective treatments
are available for ageing-related neurodegenerative disea
74 Primary outcome data
were available for all 593 patients.
75 Live birth outcomes
were available for all couples, and 1629 men (69%) had s
76 No global burden estimates
are available for ALRIs associated with human metapneumo
77 Of 160 patients enrolled, 149
were available for analyses.
78 ics), where limited amounts of glycoproteins
are available for analysis.
79 Further data releases will
be available for analysis as recruitment at the VA conti
80 of genetically engineered material that may
be available for analysis.
81 Forty-nine patients/130 sites
were available for analysis at T2 whereas 44 patients/12
82 Clinical data
were available for analysis from 38 patients, including
83 Dietary surveys
were available for analysis from 614 (77%), and 561 (71%
84 Serial data
were available for analysis from 70 patients (LLL <0.5 m
85 categories: <5, 5-10, >10 kg; 1033 patients
were available for analysis.
86 nts (aspirin n = 83,529, control n = 81,973)
were available for analysis.
87 yes) of 314 patients (88.5% of 355 patients)
were available for analysis.
88 Samples from 135 patients
were available for analysis.
89 After inclusion/exclusion criteria, 316 eyes
were available for analysis; 131 eyes had MMC delivered
90 ometric holes in the photonic circuit, which
are available for analyte detection with high efficiency
91 Yet, hitherto no tool
was available for analyzing the quality of, subsampling,
92 No specific medical or genetic therapies
are available for any type of EDS.
93 use of the extensive genome information that
is available for Arabidopsis thaliana and measure how ma
94 Very few PA values
are available for basic organic monoradicals and none fo
95 However, no information
is available for bovine CYP3A (bCYP3A).
96 Water quality guidance values for Legionella
are available for building managers but are generally no
97 While many techniques
are available for characterization of pure, homogeneous
98 autoimmune disorders, but no TLR7 antagonist
is available for clinical use to date.
99 esearch site where multidecadal measurements
are available for comparison, we show that if turnover i
100 A total of 29 VTs
were available for comparison.
101 panding policy scope requires more land than
is available for compensation activities.
102 Forty-five ECGs
were available for corrected QT interval (QTc) measureme
103 strategies for the Smith-Waterman algorithm
are available for CPUs.
104 Currently no integrated and guided procedure
is available for data preparation and subsequent interpr
105 robes for intracellular calcium imaging have
been available for decades, the development of probes fo
106 Although methods
are available for deuterium incorporation at both early
107 No clinical blood tests
are available for diagnosis or disease monitoring.
108 analysis is data availability, as fewer data
are available for diversion programs than for more estab
109 heir uncertainties for eastern US NEON sites
are available for download, and are being expanded to th
110 possible; because they are exothermic, heat
is available for downstream protein processing; because
111 cularly when only a few visual field results
are available for each eye.
112 Currently, no curative treatment
is available for early-to-intermediate stage HCC, charac
113 zwitterionic/cationic PFAS molecules in vivo
are available for enzymatic degradation.
114 Currently, no approaches
are available for evaluating the resolving capability of
115 The g-iELISA kit
is available for evaluation in reference laboratories in
116 useful when only a limited amount of sample
is available, for example, polyolefin film layers or the
117 nterfaces to domain experts, limited support
is available for figure display, project management, and
118 e for VOD/SOS diagnosis, where detailed data
were available for final analysis.
119 Hence, additional Zr sites must
be available for formate formation.
120 arrying insertions for vitamin pathway genes
are available for free, public distribution via the Maiz
121 nt in theranostics, a variety of new targets
are available for further clinical investigation.
122 19 patients at PUH and other UPMC hospitals
were available for further analysis, including whole-gen
123 Several programs
are available for gene finding, yet it is currently uncl
124 ontext of the partner; (iii) since more data
are available for general protein-protein interactions,
125 Limited treatment data
are available for hepatitis C virus (HCV) in sub-Saharan
126 mensional genomics and epigenomics data that
are available for hundreds of cell types, this model ena
127 Tools based on clinical factors
are available for identifying patients at risk, but only
128 rnaria challenge, suggesting that more IL-33
was available for ILC2 activation and that a COX product
129 ffer a novel form of CAR-T-cell product that
is available for immediate clinical use, thereby broaden
130 ens following chemotherapy from 192 patients
were available for immunohistochemical analysis.
131 PINCER
is available for individual gene knockout and genome-wid
132 Structural information
is available for individual P domains from different par
133 Diverse wheat germplasm resources
are available for industrial production and breeding sel
134 Nevertheless, no structural information
is available for inhibitors bound to human CRM1 ((Hs)CRM
135 whole body autopsy reports and brain tissue
were available for interrogation was established.
136 Although structures
are available for isolated ClpX and ClpP rings, it remai
137 Many effective vaccines
are available for JE, and the use of a recently develope
138 evolutionary selection if reliable estimates
are available for key background parameters and ten or m
139 Few estimates
were available for later stages of the treatment cascade
140 However, since limited analytical approaches
are available for longitudinal traits, these data are of
141 city of the state-of-the-art techniques that
are available for mammalian cells.
142 Although high-throughput methods
are available for mapping brain-wide activity and transc
143 ains unclear, in part because no rapid assay
is available for measuring the changes in Pol II pausing
144 Although many structures
are available for members of this family, none exhibits
145 lonization capacity when glucose or fructose
is available for metabolism.
146 Ninety manual annotations
were available for model training and validation.
147 solid-state structures, however, few options
are available for modifying their outer pores to impart
148 llenging problem, as few rational approaches
are available for modulating the reactivity of this spec
149 cumulative follow-up, mortality information
was available for more than 98%.
150 imited by sample availability, but sequences
were available for more than 40% of diagnoses.
151 mic case studies where comparable phenotypes
were available for mouse and human inflammatory diseases
152 ple comprised 3641 PWID; data from 2712 PWID
were available for multivariate analysis after further r
153 However, no information
is available for NSAID-induced urticarial/angioedema (NI
154 etermined as sufficiently low and the animal
is available for observation.
155 creased for all items when prior information
was available for one of the items.
156 is not surprising that neuroanatomical data
are available for only one genus within the group-Pleuro
157 iseases, good coverage of their interactions
is available for only a fraction of the 535 human kinase
158 Because genotypic information
was available for only 257 hybrids, we used the genomic
159 al condition, radiologic response assessment
was available for only 46 of the 50 patients.
160 large scale differential binding sites (DBS)
were available for only H3K4me3 in the susceptible culti
161 eveloping fetus and only limited safety data
are available for others.
162 erfaces, whilst ensuring the latest versions
are available for our users.
163 als and 7461 end-stage kidney disease events
were available for our primary outcome analysis.
164 Effective options
are available for patients who may be pregnant, those wh
165 Finally, we review the treatments that
are available for patients with CPVT, their efficacy, an
166 rtality for which only palliative treatments
are available for patients with late-stage disease.
167 Few effective treatments
are available for patients with metastatic MCC.
168 nd in some populations, but limited evidence
is available for positive longer-term outcomes and for e
169 No satisfactory canonical treatment
is available for post-kala-azar dermal leishmaniasis (PK
170 lly evaluated using the DeltaSUV(max) method
were available for post hoc assessment of the Deauville
171 Limited data
are available for pregnant women with COVID-19 pneumonia
172 Of these participants, 819 (84.8%)
were available for primary outcome analysis at 6-month f
173 05 stations-a significantly larger pool than
was available for prior studies.
174 nd 1,192,414 single-nucleotide polymorphisms
were available for PRS-analyses.
175 e license and all datasets used in the paper
are available for public download.
176 MetaHipMer
is available for public use under an open source license
177 spectrum_utils
is available for Python 3.6+, includes extensive online
178 s Rab6-dependent pool of recycled MR1, which
is available for reloading with ligands from bacterial p
179 atching epigenomic developmental matrix, and
are available for researchers to further mine and integr
180 However, only few
are available for routine diagnosis, and many are restri
181 ipheral artery disease; however, no solution
is available for safe and reliable use in the tortuous v
182 Even though a number of methods and tools
are available for sample size calculation for microarray
183 sepsis and 28 of the bypass surgery subjects
were available for screening with an aptamer-based prote
184 Fifty-five patients
were available for statistical analysis (test group, n =
185 alth by affecting the behavioural roles that
are available for students to perform, the resources ava
186 Now, RNA-seq methods
are available for studying many different aspects of RNA
187 Hitherto, no animal model has
been available for studying in vivo the pathogenicity of
188 ch discussions, an adequate body of evidence
is available for support, and patients are generally rec
189 tage, so 2039 and 2093 patients respectively
were available for survival analysis.
190 imen types for each test?" and "What options
are available for T. pallidum molecular epidemiology?" T
191 specially when only limited clinical samples
are available for testing, and the importance of a multi
192 ers of disease outbreak when no STEC isolate
is available for testing.
193 Few methods
are available for the catalytic activation of hydroxy fu
194 munoprecipitation and sequencing (MeRIP-seq)
are available for the detection of mRNA modifications.
195 Accurate methods
are available for the investigation of other neurodegene
196 Several effective treatment options
are available for the most common types of UI (stress, u
197 Myriad interventions
are available for the treatment of actinic keratosis loc
198 Currently, no FDA approved drugs or vaccines
are available for the treatment of LASV fever.
199 c agonists and antagonists of catecholamines
are available for the treatment of some disorders.
200 particular, in detection, evidence can only
be available for the presence, not the absence, of a tar
201 on and immunoprecipitation experiments, will
be available for the same samples.
202 To date, no reliable tools have
been available for the meta-analysis of surface-based mo
203 an organized pedigree visualization platform
is available for the accessions and cultivars in rice br
204 vel viruses in NGS data, no appropriate tool
is available for the classification and identification o
205 Little information
is available for the determination of glucose within glu
206 3.6% to 11% of the total Fe in the sediments
was available for the reduction of DNAN and its partiall
207 Four hundred twelve eyes
were available for the analyses.
208 Data from 136 participants
were available for the intention-to-treat analysis of th
209 nmeasured confounding and no laboratory data
were available for the majority of patients, and molecul
210 Data from 89 evaluable patients
were available for the purpose of analysis comprising an
211 e their utility few simple catalytic methods
are available for their synthesis in high enantiopurity.
212 bioactive molecules, and a number of methods
are available for their synthesis.
213 What information
is available for them?
214 No specific therapies
are available for these abnormalities.
215 cleotide short tandem repeat (diSTR) markers
are available for this and similar purposes, they have c
216 Currently, no disease-modifying therapies
are available for this group of disorders.
217 While programmes
are available for this, there is a need for a real-time
218 ffects, Tumor Response Supplemental material
is available for this article.
219 Supplemental material
is available for this article.
220 (C) RSNA, 2019 Online supplemental material
is available for this article.
221 (C) RSNA, 2020 Online supplemental material
is available for this article.
222 Graphical Abstract: A graphical abstract
is available for this article.
223 ts, Oncology, Pancreas Supplemental material
is available for this article.
224 (C) RSNA, 2020 Supplemental material
is available for this article.
225 Visual Overview: A visual overview
is available for this article.
226 Graphic Abstract: An graphic abstract
is available for this article.
227 Graphic Abstract: A graphic abstract
is available for this article.
228 Visual Overview A visual overview
is available for this article.
229 (C) RSNA, 2021 Online supplemental material
is available for this article.
230 (C) RSNA, 2018 Online supplemental material
is available for this article.
231 (C)RSNA, 2019 Online supplemental material
is available for this article.
232 s.Visual Overview: An online visual overview
is available for this article.
233 Graphic Abstract: An online graphic abstract
is available for this article.
234 y.(C) RSNA, 2019Online supplemental material
is available for this article.
235 Visual Overview: An online visual overview
is available for this article.
236 ping sequence at 1.5 T.Supplemental material
is available for this article.(C) RSNA, 2020.
237 with synthetic lesions.Supplemental material
is available for this article.(C) RSNA, 2020.
238 d attending physicians.Supplemental material
is available for this article.(C) RSNA, 2020.
239 mmon and rare diseases.Supplemental material
is available for this article.(C) RSNA, 2020.
240 monia is nonnegligible.Supplemental material
is available for this article.(C) RSNA, 2020.
241 f PE risk and severity.Supplemental material
is available for this article.(C) RSNA, 2020.
242 ers in lethal COVID-19.Supplemental material
is available for this article.(C) RSNA, 2020.
243 linical staging of MPM.Supplemental material
is available for this article.(C) RSNA, 2020.
244 -Quantitative, PancreasSupplemental material
is available for this article.(C) RSNA, 2020.
245 etection of MVI in HCC.Supplemental material
is available for this article.(C) RSNA, 2020.
246 ctional image analysis.Supplemental material
is available for this article.(C) RSNA, 2020.
247 ghted Imaging, OncologySupplemental material
is available for this article.(C) RSNA, 2020.
248 s with SSc-related ILD.Supplemental material
is available for this article.(C) RSNA, 2020.
249 rger training datasets.Supplemental material
is available for this article.(C) RSNA, 2020.
250 ans demonstrating iNPH.Supplemental material
is available for this article.(C) RSNA, 2020.
251 lying vascular process.Supplemental material
is available for this article.(C) RSNA, 2020.
252 ith the proposed DCNet.Supplemental material
is available for this article.(C) RSNA, 2020.
253 of 1280 x 1024 pixels.Supplemental material
is available for this article.(C) RSNA, 2020.
254 eproductive, UltrasoundSupplemental material
is available for this article.(C) RSNA, 2020.
255 e to radiation from CT.Supplemental material
is available for this article.(C) RSNA, 2020.
256 out airway obstruction.Supplemental material
is available for this article.(C) RSNA, 2020.
257 reconstructed volumes.Supplemental material
is available for this article.(C) RSNA, 2020.
258 f neurologic disorders.Supplemental material
is available for this article.(C) RSNA, 2020.
259 he content in the MIPs.Supplemental material
is available for this article.(C) RSNA, 2020.
260 nd risk stratification.Supplemental material
is available for this article.(C) RSNA, 2020.
261 evere MV regurgitation.Supplemental material
is available for this article.(C) RSNA, 2020.
262 es outcome predictions.Supplemental material
is available for this article.(C) RSNA, 2020.
263 ve Studies, Large BowelSupplemental material
is available for this article.(C) RSNA, 2020.
264 vasive CAD diagnostics.Supplemental material
is available for this article.(C) RSNA, 2020.
265 oth anatomic locations.Supplemental material
is available for this article.(C) RSNA, 2020.
266 intraobserver analyses.Supplemental material
is available for this article.(C) RSNA, 2020.
267 the COVID-19 pandemic.Supplemental material
is available for this article.(C) RSNA, 2020.
268 al, MR-Imaging, UrinarySupplemental material
is available for this article.(C) RSNA, 2020.
269 d paravalvular leakage.Supplemental material
is available for this article.(C) RSNA, 2020.
270 e acute safety profile.Supplemental material
is available for this article.(C) RSNA, 2020.
271 splenic volume changes.Supplemental material
is available for this article.(C) RSNA, 2020.
272 ch to estimate E/E (m).Supplemental material
is available for this article.(C) RSNA, 2020.
273 longing their workflow.Supplemental material
is available for this article.(C) RSNA, 2020.
274 ate clinical workflows.Supplemental material
is available for this article.(C) RSNA, 2020See also com
275 ation of immunotherapy.Supplemental material
is available for this article.(C) RSNA, 2020See also the
276 erences in acquisition.Supplemental material
is available for this article.(C) RSNA, 2020See also the
277 s used to perform them.Supplemental material
is available for this article.(C) RSNA, 2020See also the
278 pediatric populations.Supplemental material
is available for this article.(C) RSNA, 2020See also the
279 by using few SM images.Supplemental material
is available for this article.Published under a CC BY 4.
280 and site-specific data.Supplemental material
is available for this article.Published under a CC BY 4.
281 adult patients with CF.Supplemental material
is available for this article.See also the commentary by
282 ets and trained models.Supplemental material
is available for this article.See also the commentary by
283 ysis, Prostate, StagingSupplemental material
is available for this article.See also the commentary by
284 invasive PH evaluation.Supplemental material
is available for this article.See also the commentary by
285 d.(C) RSNA, 2020Online supplemental material
is available for this article.See also the editorial by
286 s.(C) RSNA, 2020Online supplemental material
is available for this article.See also the editorial by
287 s.(C) RSNA, 2020Online supplemental material
is available for this article.See also the editorial by
288 e.(C) RSNA, 2019Online supplemental material
is available for this article.See also the editorial by
289 s.(C) RSNA, 2019Online supplemental material
is available for this article.See also the editorial by
290 d.(C) RSNA, 2019Online supplemental material
is available for this article.See also the editorial by
291 h.(C) RSNA, 2019Online supplemental material
is available for this article.See also the editorial by
292 g.(C) RSNA, 2020Online supplemental material
is available for this article.See also the editorial by
293 d.(C) RSNA, 2019Online supplemental material
is available for this article.See also the editorial by
294 Limited genotype by environment information
is available for traits valued by consumers.
295 A subgroup of patients
was available for tryptase genotyping.
296 A total of 10 patients who
were available for tryptase genotyping were all confirme
297 At present, no approved pharmacotherapies
are available for unclassifiable interstitial lung disea
298 how much light and thus how much information
is available for visual processing.
299 s the retina and, thus, how much information
is available for visual processing.
300 Where evidence
is available for y-ome genes, it most often points to th